tm logo
LAVENGEL
Live/Registered
REGISTERED

on 29 Dec 2020

Last Applicant/ Owned by

SUITE B

ST. CHARLES

IL

60174

Serial Number

88427217 filed on 13th May 2019

Registration Number

6234553 registered on 29th Dec 2020

in the Principal Register

Correspondent Address

April L. Besl

April L. Besl

255 East Fifth Street

Suite 1900

CINCINNATI, OH 45202

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LAVENGEL

Pharmaceutical skincare products for animals used for healing skin disruptions, particularly, lick granulomas, mange, insect bites, dermatitis, abrasions, itchy skin, wounds, burns, surgical incision, shingles lesions, cold sores, methicillin resistant staphylococcus aureus (MRSA) and methicillin resistant staphylococcus pseudintermedius (MRSP)

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical skincare products for animals used for healing skin disruptions, particularly, lick granulomas, mange, insect bites, dermatitis, abrasions, itchy skin, wounds, burns, surgical incision, shingles lesions, cold sores, methicillin resistant staphylococcus aureus (MRSA) and methicillin resistant staphylococcus pseudintermedius (MRSP)


First Use Date in General

27th May 2020

First Use Date in Commerce

27th May 2020

Mark Details


Serial Number

No 88427217

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 37156

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Feb 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
29th Dec 2020REGISTERED-PRINCIPAL REGISTER
24th Nov 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21st Nov 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12th Nov 2020STATEMENT OF USE PROCESSING COMPLETE
12th Nov 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
29th Oct 2020USE AMENDMENT FILED
29th Oct 2020TEAS STATEMENT OF USE RECEIVED
22nd May 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20th May 2020SOU EXTENSION 1 GRANTED